Investment in JOLED and outsourced R&D
First written in FY2017. 3 of 16 entries say "Advanced", first in FY2020-Q2. Latest entry: 2026-05-28.
0 other companies' latest entry also says "Achieved".
- FY2024-Q1AdvancedAnnual report
「The company completed the acquisition of the relevant business on 18 July of the same year. This decision was based on the assessment that taking over the talented personnel, intellectual property and know-how of JOLED’s technology development business, which was undergoing civil rehabilitation proceedings, would contribute to creating value for the company’s customers and shareholders.」
Following the termination of the capital relationship with JOLED, the transfer of the OLED technology development business, personnel, intellectual property rights, and know-how was completed. - FY2023AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors meeting held on 27 March 2023, the Company entered into a basic agreement with JOLED Inc. on the same date regarding sponsor support.」
After ending its capital relationship with JOLED, the Company entered into a basic agreement concerning sponsor support and, after the filing date, progressed to a business transfer agreement to acquire its technology development business, intellectual property rights, know-how and personnel. - FY2020-Q3Completion of the termination of the capital relationship with JOLEDAnnual report
「In connection with this share transfer, JOLED has been excluded from the Company's equity-method affiliates.」
Regarding JOLED, the company progressed from a relationship premised on an investment and application of the equity method to the stage of transferring all shares to INCJ and removing JOLED from the list of equity-method affiliates. - FY2020-Q2AdvancedAnnual report
「On 27 August 2019, the company entered into a definitive agreement with INCJ to transfer all shares of JOLED to INCJ as an in-kind repayment totaling ¥46.32 billion, comprising the full amount of borrowings with a total principal of ¥20 billion under the loan agreement dated 18 April 2019 and ¥26.32 billion of the subordinated loan from INCJ with a total principal of ¥30 billion, in part, on the same date as the execution of the third-party allotment of the new shares and the third-party allotment of the second series of bonds with stock acquisition rights.」
The policy of ending the capital relationship with JOLED progressed to the execution of a definitive agreement under which all shares would be transferred to INCJ and applied toward the settlement in kind of total liabilities of ¥46.32 billion. However, execution is conditional on factors including a private placement to Suwa. - FY2020-Q1Continuation of equity-method investment lossesAnnual report
「Ordinary loss was ¥31,617 million, mainly due to the recognition of an equity-method investment loss of ¥2,031 million in non-operating expenses.」
The Company recorded an equity-method investment loss of ¥2,031 million related to JOLED and other entities. The investment loss continued from the previous fiscal year, but decreased from ¥3,071 million in the same quarter of the previous year. - FY2019ReframedAnnual report
「Although the company plans to dissolve its capital relationship with the other company, the business relationship between the two companies is expected to continue.」
The relationship with JOLED was planned to change from continued investment and application of the equity method to continued business cooperation while ending the capital relationship. The filing also stated that, after the filing date, all shares were planned to be transferred to INCJ as payment in kind. - FY2019-Q3Equity-method investment losses continued and decreased year on yearAnnual report
「The ordinary loss was ¥19,727 million, due in part to the recognition of a foreign exchange gain of ¥2,487 million and an equity-method investment loss of ¥6,728 million, compared with an ordinary loss of ¥58,536 million in the same cumulative period of the previous year.」
An equity-method investment loss of ¥6,728 million related to JOLED and others was recorded. Although this was down from ¥10,032 million in the prior-year period, equity-method investment losses have continued. - FY2019-Q2Continued equity-method investment lossesAnnual report
「The ordinary loss was ¥19,029 million, due mainly to the recording of a ¥3,815 million foreign exchange gain in non-operating income and a ¥4,941 million equity-method investment loss, compared with an ordinary loss of ¥40,178 million in the same cumulative quarter of the previous year.」
During the cumulative period, the company recorded an equity-method investment loss of ¥4,941 million. Separately from the ¥11,943 million gain on the change in equity interest associated with JOLED’s capital increase in the first quarter, the equity-method investment loss continued. - FY2019-Q1Recording of gains from the JOLED capital increase and changes in ownership interestsAnnual report
「In addition, following a capital increase by equity-method affiliate JOLED, the company recorded a ¥11,943 million gain on changes in equity interests as extraordinary income.」
The Company recognized an equity-method valuation gain of ¥11,943 million in the quarter in connection with JOLED’s capital increase. A new accounting-related change arose in the Company’s relationship with JOLED as a result of the capital increase. - FY2018Additional capital contributions and expanded investment lossesAnnual report
「New share subscription 6,500」
Although the company subscribed for ¥6,500 million of new shares in JOLED during the fiscal year, its equity-method investment loss related to JOLED amounted to ¥14,162 million. - FY2018-Q3Increase in equity-method investment lossesAnnual report
「Ordinary loss totaled ¥58,536 million, compared with an ordinary loss of ¥9,050 million in the same cumulative period of the previous year, due mainly to an equity-method investment loss of ¥10,032 million recorded as a non-operating expense and depreciation of ¥6,611 million.」
Equity-method investment losses were ¥10,032 million, up from ¥6,455 million through the cumulative period of the previous quarter. - FY2018-Q2Increase in equity-method investment lossesAnnual report
「The ordinary loss was ¥40,178 million, mainly because the company recorded an equity-method investment loss of ¥6,455 million in non-operating expenses.」
The equity-method investment loss related to JOLED and other entities amounted to ¥6,455 million, up from the ¥2,811 million reported through the previous cumulative quarter. - FY2018-Q1Recognition of an Equity-Method Investment LossAnnual report
「Equity-method investment loss 2,811」
For equity-method affiliates including JOLED, the company recorded an equity-method investment loss of ¥2,811 million during the quarter. No new developments in investments or research and development relationships themselves were disclosed. - FY2017First statedAnnual report
「㈱JOLED has applied the equity method from the consolidated fiscal year under review because its materiality has increased.」
The company began applying the equity method to JOLED and disclosed a ¥19,750 million subscription for new shares and its relationship with JOLED as a research and development contractor.